Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 616

1.

Lysophosphatidic acid receptor, LPA6, regulates endothelial blood-brain barrier function: Implication of hepatic encephalopathy.

Masago K, Kihara Y, Yanagida K, Hamano F, Nakagawa S, Niwa M, Shimizu T.

Biochem Biophys Res Commun. 2018 May 17. pii: S0006-291X(18)31169-0. doi: 10.1016/j.bbrc.2018.05.106. [Epub ahead of print]

PMID:
29778535
2.

Platelets, autotaxin and lysophosphatidic acid signaling: win-win factors for cancer metastasis.

Leblanc R, Houssin A, Peyruchaud O.

Br J Pharmacol. 2018 May 19. doi: 10.1111/bph.14362. [Epub ahead of print] Review.

PMID:
29777586
3.

Lysophosphatidylcholine as a predictor of postoperative complications after colorectal cancer surgery.

Matsuda A, Yamada M, Matsumoto S, Sakurazawa N, Yamada T, Matsutani T, Miyashita M, Uchida E.

Surg Today. 2018 May 17. doi: 10.1007/s00595-018-1675-2. [Epub ahead of print]

PMID:
29774420
4.

Synaptic phospholipids as a new target for cortical hyperexcitability and E/I balance in psychiatric disorders.

Thalman C, Horta G, Qiao L, Endle H, Tegeder I, Cheng H, Laube G, Sigrudsson T, Hauser MJ, Tenzer S, Distler U, Aoki J, Morris AJ, Geisslinger G, Röper J, Kirischuk S, Luhmann HJ, Radyushkin K, Nitsch R, Vogt J.

Mol Psychiatry. 2018 May 9. doi: 10.1038/s41380-018-0053-1. [Epub ahead of print]

PMID:
29743582
5.

The autotaxin - lysophosphatidic acid axis promotes lung carcinogenesis.

Magkrioti C, Oikonomou N, Kaffe E, Mouratis MA, Xylourgidis N, Barbayianni I, Megadoukas P, Harokopos V, Valavanis C, Chun J, Kosma A, Stathopoulos GT, Bouros E, Bouros D, Syrigos KN, Aidinis V.

Cancer Res. 2018 May 3. pii: canres.3797.2017. doi: 10.1158/0008-5472.CAN-17-3797. [Epub ahead of print]

PMID:
29724718
6.

Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis.

Al-Dury S, Wahlström A, Wahlin S, Langedijk J, Elferink RO, Ståhlman M, Marschall HU.

Sci Rep. 2018 Apr 27;8(1):6658. doi: 10.1038/s41598-018-25214-0.

7.

Lysophosphatidic Acid Induces ECM Production via Activation of the Mechanosensitive YAP/TAZ Transcriptional Pathway in Trabecular Meshwork Cells.

Ho LTY, Skiba N, Ullmer C, Rao PV.

Invest Ophthalmol Vis Sci. 2018 Apr 1;59(5):1969-1984. doi: 10.1167/iovs.17-23702.

8.

Correction to Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2- a]pyridine Series of Autotaxin Inhibitors.

Joncour A, Desroy N, Housseman C, Bock X, Bienvenu N, Cherel L, Labeguere V, Peixoto C, Annoot D, Lepissier L, Heiermann J, Hengeveld WJ, Pilzak G, Monjardet A, Wakselman E, Roncoroni V, Le Tallec S, Galien R, David C, Vandervoort N, Christophe T, Conrath K, Jans M, Wohlkonig A, Soror S, Steyaert J, Touitou R, Fleury D, Vercheval L, Mollat P, Triballeau N, van der Aar E, Brys R, Heckmann B.

J Med Chem. 2018 May 10;61(9):4270. doi: 10.1021/acs.jmedchem.8b00579. Epub 2018 Apr 19. No abstract available.

PMID:
29672037
9.

Is patient-reported outcome improved by nalfurafine hydrochloride in patients with primary biliary cholangitis and refractory pruritus? A post-marketing, single-arm, prospective study.

Yagi M, Tanaka A, Namisaki T, Takahashi A, Abe M, Honda A, Matsuzaki Y, Ohira H, Yoshiji H, Takikawa H; Japan PBC Study Group (JPBCSG).

J Gastroenterol. 2018 Apr 16. doi: 10.1007/s00535-018-1465-z. [Epub ahead of print]

PMID:
29663077
10.

Role of lysophosphatidic acid in the retinal pigment epithelium and photoreceptors.

Lidgerwood GE, Morris AJ, Conquest A, Daniszewski M, Rooney LA, Lim SY, Hernández D, Liang HH, Allen P, Connell PP, Guymer RH, Hewitt AW, Pébay A.

Biochim Biophys Acta. 2018 Jul;1863(7):750-761. doi: 10.1016/j.bbalip.2018.04.007. Epub 2018 Apr 13.

PMID:
29660533
11.

LPAR2 and LPAR4 are the Main Receptors Responsible for LPA Actions in Ovarian Endometriotic Cysts.

Kowalczyk-Zieba I, Woclawek-Potocka I, Wasniewski T, Boruszewska D, Grycmacher K, Sinderewicz E, Staszkiewicz J, Wolczynski S.

Reprod Sci. 2018 Jan 1:1933719118766263. doi: 10.1177/1933719118766263. [Epub ahead of print]

PMID:
29621954
12.

Hydroxamic Acids Constitute a Novel Class of Autotaxin Inhibitors that Exhibit in Vivo Efficacy in a Pulmonary Fibrosis Model.

Nikolaou A, Ninou I, Kokotou MG, Kaffe E, Afantitis A, Aidinis V, Kokotos G.

J Med Chem. 2018 Apr 26;61(8):3697-3711. doi: 10.1021/acs.jmedchem.8b00232. Epub 2018 Apr 18.

PMID:
29620892
13.

Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C.

Yamazaki T, Joshita S, Umemura T, Usami Y, Sugiura A, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Ota M, Tanaka E.

PLoS One. 2018 Apr 4;13(4):e0195632. doi: 10.1371/journal.pone.0195632. eCollection 2018.

14.

Expression of genes for enzymes synthesizing lysophosphatidic acid, its receptors and follicle developmental factors derived from the cumulus-oocyte complex is dependent on the ovarian follicle type in cows.

Sinderewicz E, Grycmacher K, Boruszewska D, Kowalczyk-Zięba I, Staszkiewicz-Chodor J, Łukaszuk K, Wocławek-Potocka I.

Anim Reprod Sci. 2018 May;192:242-250. doi: 10.1016/j.anireprosci.2018.03.018. Epub 2018 Mar 19.

PMID:
29573844
15.

Lysophosphatidic Acid Signaling in Obesity and Insulin Resistance.

D'Souza K, Paramel GV, Kienesberger PC.

Nutrients. 2018 Mar 23;10(4). pii: E399. doi: 10.3390/nu10040399. Review.

16.

Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease.

Fujimori N, Umemura T, Kimura T, Tanaka N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Usami Y, Sano K, Igarashi K, Matsumoto A, Tanaka E.

World J Gastroenterol. 2018 Mar 21;24(11):1239-1249. doi: 10.3748/wjg.v24.i11.1239.

17.

Measurement of plasma choline in acute coronary syndrome: importance of suitable sampling conditions for this assay.

Ohkawa R, Kurano M, Sakai N, Kishimoto T, Nojiri T, Igarashi K, Hosogaya S, Ozaki Y, Dohi T, Miyauchi K, Daida H, Aoki J, Okubo S, Ikeda H, Tozuka M, Yatomi Y.

Sci Rep. 2018 Mar 16;8(1):4725. doi: 10.1038/s41598-018-23009-x.

18.

Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation.

Benesch MGK, MacIntyre ITK, McMullen TPW, Brindley DN.

Cancers (Basel). 2018 Mar 15;10(3). pii: E73. doi: 10.3390/cancers10030073. Review.

19.

Alkaline sphingomyelinase (NPP7) in hepatobiliary diseases: A field that needs to be closely studied.

Duan RD.

World J Hepatol. 2018 Feb 27;10(2):246-253. doi: 10.4254/wjh.v10.i2.246. Review.

20.

Association between serum autotaxin or phosphatidylserine-specific phospholipase A1 levels and melanoma.

Kurano M, Miyagaki T, Miyagawa T, Igarashi K, Shimamoto S, Ikeda H, Aoki J, Sato S, Yatomi Y.

J Dermatol. 2018 May;45(5):571-579. doi: 10.1111/1346-8138.14278. Epub 2018 Mar 3.

PMID:
29500864

Supplemental Content

Loading ...
Support Center